Cargando…

UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis

Identification of new genetic pathways or molecular targets that sensitize cancer cells to chemotherapeutic drugs may improve the efficacy of current chemotherapy. Here, we report that downmodulation of UHRF1 (ubiquitin‐like with PHD and RING finger domains 1) in retinoblastoma (RB) cells increases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jong Kyong, Kan, Guangyan, Mao, Yu, Wu, Zhixuan, Tan, Xionghong, He, Heng, Lee, Chunsik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998393/ https://www.ncbi.nlm.nih.gov/pubmed/31782885 http://dx.doi.org/10.1002/1878-0261.12607

Ejemplares similares

UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
por: He, Heng, et al.
Publicado: (2018)

Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome
por: Kan, Guangyan, et al.
Publicado: (2017)

Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy
por: Mao, Yu, et al.
Publicado: (2021)

Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities
por: Lee, Chunsik, et al.
Publicado: (2022)

Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications
por: Lee, Chunsik, et al.
Publicado: (2020)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells
por: Yu, Na, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
por: Zhao, Na, et al.
Publicado: (2020)

Oxidative downmodulation of T cell-mediated cytotoxicity
por: Wabnitz, Guido H, et al.
Publicado: (2016)

Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression
por: Benavente, Claudia A., et al.
Publicado: (2014)

Mitochondrial Apoptosis and FAK Signaling Disruption by a Novel Histone Deacetylase Inhibitor, HTPB, in Antitumor and Antimetastatic Mouse Models
por: Shieh, Jiunn-Min, et al.
Publicado: (2012)

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with l-phenylglycine scaffold
por: Zhang, Yingjie, et al.
Publicado: (2015)

Interferon Regulatory Factor-8 Is Important for Histone Deacetylase Inhibitor-Mediated Antitumor Activity
por: Banik, Debarati, et al.
Publicado: (2012)

Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer()
por: Zhang, Tao, et al.
Publicado: (2014)

Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
por: Mei, Qinglang, et al.
Publicado: (2023)

Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils
por: Kankaanranta, Hannu, et al.
Publicado: (2010)

Arabidopsis Homologs of Retinoblastoma-Associated Protein 46/48 Associate with a Histone Deacetylase to Act Redundantly in Chromatin Silencing
por: Gu, Xiaofeng, et al.
Publicado: (2011)

Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells
por: Bordonaro, Michael
Publicado: (2020)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells
por: Gueugnon, Fabien, et al.
Publicado: (2014)

Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
por: Stankov, Metodi V., et al.
Publicado: (2013)

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor
por: Ashry, Ramy, et al.
Publicado: (2023)

A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer
por: Tang, Yen-An, et al.
Publicado: (2010)

A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer
por: Zhang, Tao, et al.
Publicado: (2017)

Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways
por: Pichler, Garwin, et al.
Publicado: (2011)

Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach
por: Wang, Lihui, et al.
Publicado: (2015)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
por: Zhang, Baojie, et al.
Publicado: (2019)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells
por: Kim, Jong Kyong, et al.
Publicado: (2009)

Histone deacetylase inhibitory effect of Brazilian propolis and its association with the antitumor effect in Neuro2a cells
por: Ishiai, Shinobu, et al.
Publicado: (2014)

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma
por: Dias, Joana N.R., et al.
Publicado: (2018)

Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its histone recognition
por: Fang, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5miopkap1e91ai6a2fb4edqomm